Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2023-10-06 00:00:00 ET · period of report 2023-10-04 · accession 0001104659-23-107367 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-10-06 | 2023-10-04+ | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $11.01 | +3,220 | 3.23M | +0.1% | +$35.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-05 | P | A | 1,400 | $11.09 | 3,235,764 | D | — | — | (F3) Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.7875 to $11.32. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 426,759 shares of restricted stock. |
| 2 | Common | Common Stock | 2023-10-04 | P | A | 1,820 | $10.95 | 3,234,364 | D | — | — | (F1) Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.76 to $11.236. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 426,759 shares of restricted stock. |